Intrauterine programming of lipid metabolic alterations in the heart of the offspring of diabetic rats is prevented by maternal diets enriched in olive oil

Molecular Nutrition and Food Research

Volumn 59, Issue 10, 2015, Pages 1997-2007

  Capobianco, Evangelina ^a   Pelesson, Magalí ^a   Careaga, Valeria ^b   Fornes, Daiana ^a   Canosa, Ivana ^b   Higa, Romina ^a   Maier, Marta ^b   Jawerbaum, Alicia ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Diabetes in pregnancy; Intrauterine programming; Lipid metabolism; Offspring's heart; Olive oil supplementation

Indexed keywords

FATTY ACID; LINOLEOYL COENZYME A DESATURASE; NITRIC OXIDE; OLIVE OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL; BODY WEIGHT; CARDIAC MUSCLE; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; FEMALE; HEART; LIPID METABOLISM; LIPID PEROXIDATION; MALE; METABOLISM; PREGNANCY; PREGNANCY DIABETES MELLITUS; WISTAR RAT;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; FATTY ACIDS; FEMALE; HEART; LINOLEOYL-COA DESATURASE; LIPID METABOLISM; LIPID PEROXIDATION; MALE; MYOCARDIUM; NITRIC OXIDE; OLIVE OIL; PPAR ALPHA; PREGNANCY; PREGNANCY IN DIABETICS; RATS, WISTAR;

EID: 84942826245     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500334     Document Type: Article

References (48)

1. Higa, R., Jawerbaum, A., Intrauterine effects of impaired lipid homeostasis in pregnancy diseases. Curr. Med. Chem. 2013, 20, 2338-2350.
2. Zohdi, V., Lim, K., Pearson, J. T., Black, M. J., Developmental programming of cardiovascular disease following intrauterine growth restriction: findings utilising a rat model of maternal protein restriction. Nutrients 2014, 7, 119-152.
3. Visentin, S., Grumolato, F., Nardelli, G. B., Di Camillo, B. et al., Early origins of adult disease: low birth weight and vascular remodeling. Atherosclerosis 2014, 237, 391-399.
4. Miki, T., Yuda, S., Kouzu, H., Miura, T., Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail. Rev. 2013, 18, 149-166.
5. Nakanishi, T., Kato, S., Impact of diabetes mellitus on myocardial lipid deposition: an autopsy study. Pathol. Res. Pract. 2014, 210, 1018-1025.
6. Pruis, M. G., van Ewijk, P. A., Schrauwen-Hinderling, V. B., Plosch, T., Lipotoxicity and the role of maternal nutrition. Acta Physiol. 2014, 210, 296-306.
7. Wende, A. R., Abel, E. D., Lipotoxicity in the heart. Biochim. Biophys. Acta 2010, 1801, 311-319.
8. Wahli, W., Michalik, L., PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol. Metab. 2012, 23, 351-363.
9. Lefebvre, P., Chinetti, G., Fruchart, J. C., Staels, B., Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 2006, 116, 571-580.
10. Smeets, P. J., de Vogel-van den Bosch, H. M., Willemsen, P. H., Stassen, A. P. et al., Transcriptomic analysis of PPARalpha-dependent alterations during cardiac hypertrophy. Physiol. Genomics 2008, 36, 15-23.
11. Yongming, P., Zhaowei, C., Yichao, M., Keyan, Z. et al., Involvement of peroxisome proliferator-activated receptors in cardiac and vascular remodeling in a novel minipig model of insulin resistance and atherosclerosis induced by consumption of a high-fat/cholesterol diet. Cardiovasc. Diabetol. 2015, 14, 6.
12. Hihi, A. K., Michalik, L., Wahli, W., PPARs: transcriptional effectors of fatty acids and their derivatives. Cell Mol. Life Sci. 2002, 59, 790-798.
13. Slater-Jefferies, J. L., Lillycrop, K. A., Townsend, P. A., Torrens, C. et al., Feeding a protein-restricted diet during pregnancy induces altered epigenetic regulation of peroxisomal proliferator-activated receptor-alpha in the heart of the offspring. J. Dev. Orig. Health Dis. 2011, 2, 250-255.
14. Katkhuda, R., Peterson, E. S., Roghair, R. D., Norris, A. W. et al., Sex-specific programming of hypertension in offspring of late-gestation diabetic rats. Pediatr. Res. 2012, 72, 352-361.
15. Segar, E. M., Norris, A. W., Yao, J. R., Hu, S. et al., Programming of growth, insulin resistance and vascular dysfunction in offspring of late gestation diabetic rats. Clin. Sci. 2009, 117, 129-138.
16. Agoudemos, M., Reinking, B. E., Koppenhafer, S. L., Segar, J. L. et al., Programming of adult cardiovascular disease following exposure to late-gestation hyperglycemia. Neonatology 2011, 100, 198-205.
17. Corrigan, N., Treacy, A., Brazil, D. P., McAuliffe, F. M., Cardiomyopathy and diastolic dysfunction in the embryo and neonate of a type 1 diabetic mouse model. Reprod. Sci. 2013, 20, 781-790.
18. Holemans, K., Gerber, R. T., Meurrens, K., De Clerck, F. et al., Streptozotocin diabetes in the pregnant rat induces cardiovascular dysfunction in adult offspring. Diabetologia 1999, 42, 81-89.
19. Kurtz, M., Capobianco, E., Martinez, N., Roberti, S. et al., PPAR ligands improve impaired metabolic pathways in fetal hearts of diabetic rats. J. Mol. Endocrinol. 2014, 53, 237-246.
20. Kurtz, M., Capobianco, E., Careaga, V., Martinez, N. et al., Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats. J. Endocrinol. 2014, 220, 345-359.
21. Martinez, N., White, V., Kurtz, M., Higa, R. et al., Activation of the nuclear receptor PPARalpha regulates lipid metabolism in foetal liver from diabetic rats: implications in diabetes-induced foetal overgrowth. Diabetes Metab. Res. Rev. 2011, 27, 35-46.
22. Jawerbaum, A., White, V., Animal models in diabetes and pregnancy. Endocr. Rev. 2010, 31, 680-701.
23. White, V., Jawerbaum, A., Mazzucco, M. B., Gauster, M. et al., Diabetes-associated changes in the fetal insulin/insulin-like growth factor system are organ specific in rats. Pediatr. Res. 2015, 77, 48-55.
24. Plagemann, A., Harder, T., Dudenhausen, J. W., The diabetic pregnancy, macrosomia, and perinatal nutritional programming. Nestle Nutr. Workshop Ser. Pediatr. Program 2008, 61, 91-102.
25. Stradling, C., Hamid, M., Taheri, S., Thomas, G. N., A review of dietary influences on cardiovascular health: part 2: dietary patterns. Cardiovasc. Hematol. Disord. Drug Targets 2014, 14, 50-63.
26. Schwingshackl, L., Hoffmann, G., Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. Lipids Health Dis. 2014, 13, 154.
27. Sardinha, F. L., Fernandes, F. S., Tavares do Carmo, M. G., Herrera, E., Sex-dependent nutritional programming: fish oil intake during early pregnancy in rats reduces age-dependent insulin resistance in male, but not female, offspring. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 304, R313-R320.
28. Grigore, D., Ojeda, N. B., Alexander, B. T., Sex differences in the fetal programming of hypertension. Gend. Med. 2008, 5 (Suppl A), S121-S132.
29. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
30. Tang, C., Cho, H. P., Nakamura, M. T., Clarke, S. D., Regulation of human delta-6 desaturase gene transcription: identification of a functional direct repeat-1 element. J. Lipid Res. 2003, 44, 686-695.
31. McGavock, J. M., Victor, R. G., Unger, R. H., Szczepaniak, L. S. et al., Adiposity of the heart, revisited. Ann. Intern. Med. 2006, 144, 517-524.
32. Elezaby, A., Sverdlov, A. L., Tu, V. H., Soni, K. et al., Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload. J. Mol. Cell. Cardiol. 2015, 79, 275-283.
33. Vijay, V., Han, T., Moland, C. L., Kwekel, J. C. et al., Sexual dimorphism in the expression of mitochondria-related genes in rat heart at different ages. PLoS One 2015, 10, e0117047.
34. Manson, J. E., Bassuk, S. S., Biomarkers of cardiovascular disease risk in women. Metabolism 2015, 64, S33-S39.
35. Gabory, A., Attig, L., Junien, C., Sexual dimorphism in environmental epigenetic programming. Mol. Cell. Endocrinol. 2009, 304, 8-18.
36. Benz, V., Kintscher, U., Foryst-Ludwig, A., Sex-specific differences in type 2 diabetes mellitus and dyslipidemia therapy: PPAR agonists. Handb. Exp. Pharmacol. 2012, 214, 387-410.
37. Keller, H., Dreyer, C., Medin, J., Mahfoudi, A. et al., Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA 1993, 90, 2160-2164.
38. Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J. et al., Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell 1999, 3, 397-403.
39. Black, S. C., Katz, S., McNeill, J. H., Influence of omega-3 fatty acid treatment on cardiac phospholipid composition and coronary flow of streptozocin-diabetic rats. Metabolism 1993, 42, 320-326.
40. Gudbjarnason, S., el-Hage, A. N., Whitehurst, V. E., Simental, F. et al., Reduced arachidonic acid levels in major phospholipids of heart muscle in the diabetic rat. J. Mol. Cell. Cardiol. 1987, 19, 1141-1146.
41. Mann, J. I., Diet and risk of coronary heart disease and type 2 diabetes. Lancet 2002, 360, 783-789.
42. Sampath, H., Ntambi, J. M., Polyunsaturated fatty acid regulation of gene expression. Nutr. Rev. 2004, 62, 333-339.
43. Spector, A. A., Yorek, M. A., Membrane lipid composition and cellular function. J. Lipid Res. 1985, 26, 1015-1035.
44. Sanders, T. A., Protective effects of dietary PUFA against chronic disease: evidence from epidemiological studies and intervention trials. Proc. Nutr. Soc. 2014, 73, 73-79.
45. dos Santos, A. L., Weiss, T., Duarte, C. K., Gross, J. L. et al., Dietary fat composition and cardiac events in patients with type 2 diabetes. Atherosclerosis 2014, 236, 31-38.
46. Brenner, R. R., Hormonal modulation of delta6 and delta5 desaturases: case of diabetes. Prostaglandins Leukot. Essent. Fatty Acids 2003, 68, 151-162.
47. Lappas, M., Hiden, U., Desoye, G., Froehlich, J. et al., The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid. Redox Signal 2011, 15, 3061-3100.
48. Guzzardi, M. A., Iozzo, P., Fatty heart, cardiac damage, and inflammation. Rev. Diabet. Stud. 2011, 8, 403-417.